Tandem Diabetes Care
TNDM
61 hedge funds and large institutions have $300M invested in Tandem Diabetes Care in 2013 Q4 according to their latest regulatory filings, with 61 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
+$57.1M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$29.2M |
| 3 |
JP Morgan Chase
New York
|
+$27.4M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$22M |
| 5 |
Jennison Associates
New York
|
+$21.6M |
Top Sellers
TNDM Hedge Fund Activity: Q4 2013 in Review
61 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q4 2013, worth a combined $300M.
Buyers outnumbered sellers: 61 funds opened new TNDM positions and 0 closed out — a net gain of 61 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was TPG Group Holdings (SBS) Advisors, opening a new position worth an estimated $57.1M.
- 61 institutional investors held Tandem Diabetes Care (TNDM) as of Q4 2013, up from 0 in Q3 2013.
- Funds reported $300M of Tandem Diabetes Care stock for Q4 2013.
- 61 funds opened new Tandem Diabetes Care positions in Q4 2013 and 0 closed out, a net change of +61 holders.
- The largest Tandem Diabetes Care buyer in Q4 2013 was TPG Group Holdings (SBS) Advisors, an estimated $57.1M added.
Based on aggregated 13F filings for Q4 2013.